Indivior PLC (INDV)
32.97
-0.57 (-1.70%)
Inactive · Last trade price
on Jan 23, 2026
Indivior Employees
Indivior had 1,051 employees as of December 31, 2024. The number of employees decreased by 113 or -9.71% compared to the previous year.
Employees
1,051
Change (1Y)
-113
Growth (1Y)
-9.71%
Revenue / Employee
$1,180,000
Profits / Employee
$124,000
Market Cap
4.12B
Employees Chart
INDV News
- 4 days ago - Indivior Presents New Real-World Data at ASAM 2026 Annual Conference, Supporting Remission as a Treatment Outcome and Reinforcing the Clinical Benefits of Monthly Injectable Buprenorphine for Opioid Use Disorder - GlobeNewsWire
- 12 days ago - Survey of Correctional Facility Staff: Monthly Opioid Treatment Shot May Help Reduce Medication Misuse - GlobeNewsWire
- 19 days ago - Indivior to Report First Quarter 2026 Financial Results and Host Webcast on April 30th - GlobeNewsWire
- 4 weeks ago - New Cost Impact Model Highlights Potential for Monthly Injectable Buprenorphine to Reduce Staffing Burdens in Correctional Facilities - GlobeNewsWire
- 6 weeks ago - National Survey Finds Only 58% of U.S. Correctional Facilities Offer Medications for Opioid Use Disorder - GlobeNewsWire
- 6 weeks ago - Indivior Prices Upsized $450.0 Million Convertible Senior Notes Offering - GlobeNewsWire
- 6 weeks ago - Indivior Announces Proposed Convertible Senior Notes Offering - GlobeNewsWire
- 6 weeks ago - New Study Shows Adherence to Monthly Injectable Buprenorphine Linked to Lower Healthcare Utilization and Costs in Opioid Use Disorder - GlobeNewsWire